Axonal Degeneration as a target for neuroprotection
Destruction programs are cellular mechanisms that have survival value when they operate under physiological control, but their malfunction could be deleterious for the organism. Apoptosis, or programmed cell death, is a well-known physiological destruction mechanism most apparent during development but persisting throughout the organism’s life. Other destruction programs are emerging as physiological processes that may not terminate in the destruction of the whole cell but only of restricted cellular domains. In the case of neurons, pruning of exuberant branches of terminal arborizations and degeneration of axons severed from their cell bodies are outstanding examples. Importantly, axonal degeneration is an early event in neurodegenerative condition including Alzheimer´s and Parkinson disease, as well as peripheral neuropathies. We are interested to define molecular players in the process of axonal degeneration to find therapeutic targets for neuroprotection.
Golgi staining of a mouse hippocampal section, with this technique, sparse neuronal labelling is obtained, which allows detailed analysis of individual neurons.
The degeneration of axons constitutes a salient feature shared by several neurodegenerative diseases that contributes to neuronal dysfunction and cell death. To date, the precise molecular and cellular mechanisms of axonal degeneration are under intense investigation. The morphological evidence indicates that axon degeneration as a consequence of aging and neurodegenerative diseases takes place in a retrograde fashion also known as dying back degeneration, which precedes cell death of the neuronal soma. Axon degeneration shares several characteristics with cell death by activation of the necroptotic signaling pathway, including mitochondrial dysfunction, ROS production, and intracellular calcium increase, and we have found that necroptosis inhibition by genetic or pharmacological means delays axonal degeneration in neurons from the peripheral and central nervous systems, as well as in model of Alzheimer´s and Parkinson Disease.
People involved
Macarena Arrazola
PI collaborator
PhD in Biological Sciences from the Catholic University of Chile. Studying the contribution of necroptosis in the age-associated axonal degeneration of the hippocampus, and the impact of using pharmacological approaches to revert neuronal dysfunction and cognitive impairment during aging, proposing necroptosis as an attractive target for the future development of geroprotective tools to treat age-related disabilities.
Daniela Rebolledo
Senior Research Assitant
BI am a Biochemist from Pontificia Universidad Católica de Chile (PUC) and PhD in Cell and Molecular Biology from the same university. My PhD thesis research was performed at the Physiology and Biophysics department, University of Washington. My research has focused on the physiology of the neuromuscular system and the pathological mechanisms behind neuromuscular disorders of diverse etiology.
Genesis Vega
Postdoctoral fellow
Bachelor’s degree in Biochemistry at the Universidad Austral de Chile. PhD in Sciences with mention in cellular and molecular biology at the Universidad Austral de Chile carried out at CECs and University of Heidelberg. Studying the role of NAD+ imbalance in the activation of necrosome and dysfunction of mitochondrial metabolism in chemotherapy-induced axonal degeneration in aged peripheral neurons.
Rodrigo Leiva
Research Assitant
B.Sc(hons) degree in Neuroscience from the University of Glasgow and M.Sc in Integrative Neuroscience from the University of Edinburgh. I’m currently working on the role of axonal necroptosis and inflammation in the dopaminergic neurons of the nigrostriatal pathway in Parkinson’s Disease to assess it as a potential therapeutic target through the inhibition of RIPK3.
Related Publications
PUBLICATIONSDataCNSNeuroDegeneration
agosto 29, 2022
An Optimized Comparative Proteomic Approach as a Tool in Neurodegenerative Disease Research
Rachel A. Kline, Lena Lößlein, Dominic Kurian, Judit Aguilar Martí, Samantha L. Eaton,
Felipe A. Court, Thomas H. Gillingwater, and Thomas M. Wishart
PUBLICATIONSDataNervous System FxCNSNeuroDegenerationAGING
agosto 8, 2022
Commentary on «PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons»
Macarena S. Arrázola, Court FA.
PMID: 35900426
PUBLICATIONSDataCNSNeuroDegenerationAGING
junio 3, 2022
Multiple events case–control study in a prospective cohort to identify systemic, cellular, and molecular biomarkers of obesity‑induced accelerated aging in 30‑years‑olds: the ObAGE study protocol
Correa‑Burrows P, Burrows R, Albala C, Court FA, Salech F, Sanhueza G and Gonzalez‑Billault C.
PMID: 35501766
PUBLICATIONSDataCNSNeuroDegenerationAGING
marzo 24, 2022
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Natalia Salvadores, Ines Moreno‑Gonzalez, Nazaret Gamez, Gabriel Quiroz, Laura Vegas‑Gomez, Marcela Escandón, Sebastian Jimenez, Javier Vitorica, Antonia Gutierrez, Claudio Soto and Felipe A. Court.
PMID: 35264247
Related News
Del laboratorio a la sala: académicos realizan charlas y talleres para acercar la ciencia a escolares
noviembre 28, 2023
Los centros de investigación de la Universidad Mayor se vinculan con colegios de Santiago y otras regiones, entregándoles contenidos de manera didáctica y simple y una experiencia formativa en que…
Descubren rol clave de células que impiden reparar daños al sistema nervioso perférico.
noviembre 15, 2023
Descubren rol clave de células que impiden reparar daños al sistema nervioso periférico Conversación en Cooperativa Ciencia con Felipe Court, Doctor en Neurociencias, director del Centro de…